✦ LIBER ✦

Gemcitabine as frontline treatment for cutaneous T-cell lymphoma : Phase II study of 32 patients

✍ Scribed by Enrica Marchi; Lapo Alinari; Monica Tani; Vittorio Stefoni; Nicola Pimpinelli; Emilio Berti; Livio Pagano; Maria Grazia Bernengo; Francesco Zaja; Serena Rupoli; Stefano Pileri; Michele Baccarani; Pier Luigi Zinzani

Book ID: 102110767
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 94 KB
Volume: 104
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21449

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alemtuzumab plus CHOP as front-line chem

Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study

✍ Jong Gwang Kim; Sang Kyun Sohn; Yee Soo Chae; Yoon Young Cho; Deok Hwan Yang; Je 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 267 KB

Low-dose total skin electron beam therap

Low-dose total skin electron beam therapy as a debulking agent for cutaneous T-cell lymphoma: an open-label prospective phase II study

✍ M.R. Kamstrup; L.M. Lindahl; R. Gniadecki; L. Iversen; L. Skov; P.M. Petersen; A 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Multicentre phase II study of the CyclOB

Multicentre phase II study of the CyclOBEAP regimen for patients with peripheral T-cell lymphoma with analysis of biomarkers

✍ Nozomi Niitsu; Miyuki Hayama; Tadashi Yoshino; Shigeo Nakamura; Jun-Ichi Tamaru; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

A phase II study of gemcitabine plus ora

A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma

✍ Tony S. K. Mok; Benny Zee; Anthony T. C. Chan; Winnie Yeo; Wei Tse Yang; Anthony 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 3 views

A multicenter, randomized, Phase II stud

A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinoma

✍ Filippo De Marinis; Fabrizio Nelli; Marco Lombardo; Francesco Ferraú; Santi Barb 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to evaluate the activity and toxicity of combined cisplatin, etoposide, and gemcitabine (PEG) and combined cisplatin plus gemcitabine (PG) in previously untreated patients with extensive‐stage and poor‐prognosis limited‐stage small‐cell lun

RESEARCH REPORT Bexarotene capsules and

RESEARCH REPORT Bexarotene capsules and gel for previously treated patients with cutaneous T-cell lymphoma: Results of the Australian patients treated on phase II trials

✍ H Miles Prince; Christopher McCormack; Gail Ryan; Christopher Baker; Harvey Rots 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

## SUMMARY Bexarotene (Targretin^®^, LGD1069) is a novel synthetic retinoid analogue that binds selectively to retinoid X receptors. We describe eight previously treated patients who entered phase II international multicentre studies examining the role of bexarotene in cutaneous T‐cell lymphoma. Pa